Dhwani Batra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Dhwani Batra has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Agam K. Rao
National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
1 shared publication- Andrea M. McCollum
U.S. Centers for Disease Control and Prevention
1 shared publication Annette Atkinson
Utah Department of Health and Human Services, Salt Lake City, UT, USA
1 shared publicationAnthony H. Gonzalez
Sacramento County Public Health, Sacramento, CA, USA
1 shared publication- Benjamin L. Rambo-Martin
Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention
1 shared publication - Bette Korber
Los Alamos National Laboratory, Los Alamos, NM 87545, USA
1 shared publication
Latest Publications
- Top Cited Papers
- 4 November 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 378 (6619) , 560-565
Multiple lineages of monkeypox virus detected in the United States, 2021–2022
Monkeypox is a viral zoonotic disease endemic in Central and West Africa. In May 2022, dozens of non-endemic countries reported hundreds of monkeypox cases, most with no epidemiological link to Africa. We identified two lineages of monkeypox virus (MPXV) among two 2021 and seven 2022 US monkeypox cases: the major 2022 outbreak variant called B.1 and a minor contemporaneously sampled variant called A.2. Analyses of mutations among these two variants revealed an extreme preference for GA-to-AA mutations indicative of human APOBEC3 cytosine deaminase activity among Clade IIb MPXV (previously West African, Nigeria) sampled since 2017. Such mutations were not enriched within other MPXV clades. These findings suggest that APOBEC3 editing may be a recurrent and a dominant driver of MPXV evolution within the current outbreak.
- 4 November 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 378 (6619) , 560-565
Top Cited PapersMultiple lineages of monkeypox virus detected in the United States, 2021–2022
Monkeypox is a viral zoonotic disease endemic in Central and West Africa. In May 2022, dozens of non-endemic countries reported hundreds of monkeypox cases, most with no epidemiological link to Africa. We identified two lineages of monkeypox virus (MPXV) among two 2021 and seven 2022 US monkeypox cases: the major 2022 outbreak variant called B.1 and a minor contemporaneously sampled variant called A.2. Analyses of mutations among these two variants revealed an extreme preference for GA-to-AA mutations indicative of human APOBEC3 cytosine deaminase activity among Clade IIb MPXV (previously West African, Nigeria) sampled since 2017. Such mutations were not enriched within other MPXV clades. These findings suggest that APOBEC3 editing may be a recurrent and a dominant driver of MPXV evolution within the current outbreak.
- Open Access
Identification of a Novel SARS-CoV-2 Delta-Omicron Recombinant Virus in the United States
Recombination between SARS-CoV-2 virus variants can result in different viral properties (e.g., infectiousness or pathogenicity). In this report, we describe viruses with recombinant genomes containing signature mutations from Delta and Omicron variants. These genomes are the first evidence for a Delta-Omicron hybrid Spike protein in the United States.
Open AccessIdentification of a Novel SARS-CoV-2 Delta-Omicron Recombinant Virus in the United States
Recombination between SARS-CoV-2 virus variants can result in different viral properties (e.g., infectiousness or pathogenicity). In this report, we describe viruses with recombinant genomes containing signature mutations from Delta and Omicron variants. These genomes are the first evidence for a Delta-Omicron hybrid Spike protein in the United States.